摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-碘-5-甲基苯甲酸 | 52548-14-8

中文名称
2-碘-5-甲基苯甲酸
中文别名
2-碘-5-甲氧基苯甲酸
英文名称
2-iodoyl-5-methylbenzoic acid
英文别名
2-iodo-5-methylbenzoic acid;5-methyl-2-iodobenzoic acid;2-Jod-5-methyl-benzoesaeure;6-Iod-3-methyl-benzoesaeure;2-Iod-5-methylbenzoesaeure
2-碘-5-甲基苯甲酸化学式
CAS
52548-14-8
化学式
C8H7IO2
mdl
MFCD00079765
分子量
262.047
InChiKey
INGWGCDYAJKXKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    122-124°C
  • 沸点:
    321.4±30.0 °C(Predicted)
  • 密度:
    1.867±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.125
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    LIGHT SENSITIVE
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2916399090
  • WGK Germany:
    3
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H315,H319,H335
  • 储存条件:
    2~8℃

SDS

SDS:e4753525da4b662304d38c7de519e4d5
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Iodo-5-methylbenzoic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Iodo-5-methylbenzoic acid
CAS number: 52548-14-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H7IO2
Molecular weight: 262

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen Iodide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-碘-5-甲基苯甲酸copper(l) iodidepotassium carbonate 、 sodium hydroxide 作用下, 以 四氢呋喃二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 3.5h, 生成 苏沃雷生
    参考文献:
    名称:
    MK-4305的第一个大规模合成:双重Orexin受体拮抗剂,用于治疗睡眠障碍
    摘要:
    已经开发出一种新的合成途径来开发候选药物1,这是一种有效且选择性的双重orexin拮抗剂,可用于治疗睡眠障碍。关键的无环前体10是一步一步制备的,采用新颖的化学方法合成了2个取代的苯并恶唑,从市售起始原料中分离出的产率为75%。还原胺化后,通过经典拆分得到手性二氮杂庚烷(R)-11。最后,(R)-11与酸5的偶联提供了所需的候选药物1。
    DOI:
    10.1021/op1002853
  • 作为产物:
    描述:
    间甲基苯甲酸N-碘代丁二酰亚胺 、 [Ir(III)(η5-pentamethylcyclopentadienyl)(H2O)3](SO4) 作用下, 反应 16.0h, 以65%的产率得到2-碘-5-甲基苯甲酸
    参考文献:
    名称:
    苯甲酸的无碱和无添加剂Ir催化邻位碘化:范围和机理研究
    摘要:
    已经开发了一种由简单铱络合物催化的苯甲酸的C–H活化/碘化的方案。本文描述的方法允许在非常温和的条件下,在没有任何添加剂或碱的情况下,在1,1,1,3,3,3-六氟异丙醇作为溶剂中对多种苯甲酸进行邻位碘化。所用的铱催化剂可耐受空气和湿气,并选择性地以高转化率得到邻碘苯甲酸。机理研究表明,Ir(III)/ Ir(V)催化循环起作用,并且HFIP的独特性质使得能够使用羧基作为引导基团进行C-H碘化。
    DOI:
    10.1021/acscatal.7b02987
  • 作为试剂:
    描述:
    5-壬醇 在 potassium peroxymonosulfate 、 2-碘-5-甲基苯甲酸 作用下, 以 硝基甲烷 为溶剂, 反应 12.0h, 以100%的产率得到5-壬酮
    参考文献:
    名称:
    METHOD FOR PRODUCING CARBONYL COMPOUND AND PRO-OXIDANT USED FOR PRODUCTION OF CARBONYL COMPOUND
    摘要:
    公开号:
    EP2085373B8
点击查看最新优质反应信息

文献信息

  • [EN] DISUBSTITUTED OCTAHY-DROPYRROLO [3,4-C] PYRROLES AS OREXIN RECEPTOR MODULATORS<br/>[FR] OCTAHYDROPYRROLO [3,4-C] PYRROLES DISUBSTITUÉS UTILISÉS COMME MODULATEURS DU RÉCEPTEUR DE L'OREXINE
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2012145581A1
    公开(公告)日:2012-10-26
    Disubstituted octahydropyrrolo[3,4-c]pyrrole compounds are described, which are useful as orexin receptor modulators. Such compounds may be useful in pharmaceutical compositions and methods for the treatment of diseased states, disorders, and conditions mediated by orexin activity, such as insomnia.
    描述了二取代的八氢吡咯[3,4-c]吡咯化合物,这些化合物可用作促进睡眠素受体的调节剂。这些化合物可能在药物组合物和治疗由促进睡眠素活性介导的疾病状态、紊乱和病况的方法中有用,比如失眠。
  • Facile <i>N</i>-Arylation of Amines and Sulfonamides and <i>O</i>-Arylation of Phenols and Arenecarboxylic Acids
    作者:Zhijian Liu、Richard C. Larock
    DOI:10.1021/jo0602221
    日期:2006.4.1
    An efficient, transition-metal-free procedure for the N-arylation of amines, sulfonamides, and carbamates and O-arylation of phenols and carboxylic acids has been achieved by allowing these substrates to react with a variety of o-silylaryl triflates in the presence of CsF. Good to excellent yields of arylated products are obtained under very mild reaction conditions. This chemistry readily tolerates
    通过使这些底物在存在下与多种邻甲硅烷基芳基三氟甲磺酸酯反应,已实现了一种有效的,无过渡金属的胺,磺酰胺和氨基甲酸酯的N-芳基化以及酚和羧酸的O-芳基化方法。的CsF。在非常温和的反应条件下,芳基化产物的收率好至极好。这种化学反应易于耐受各种官能团。
  • [EN] USE OF BENZIMIDAZOLE-PROLINE DERIVATIVES<br/>[FR] UTILISATION DE DÉRIVÉS DE BENZIMIDAZOLE-PROLINE
    申请人:ACTELION PHARMACEUTICALS LTD
    公开号:WO2015083094A1
    公开(公告)日:2015-06-11
    The present invention relates to compounds of the formula (I), wherein Ar1 and Ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.
    本发明涉及式(I)的化合物,其中Ar1和Ar2如描述中所述,并且它们作为治疗日落综合征的药物的用途,该发明还涉及制备这种化合物及其药用盐的方法。
  • Enantioselective Copper-Catalyzed Oxy-Alkynylation of Diazo Compounds
    作者:Durga Prasad Hari、Jerome Waser
    DOI:10.1021/jacs.7b04756
    日期:2017.6.28
    Enantioselective catalytic methods allowing the addition of both a nucleophile and an electrophile onto diazo compounds give a fast access into important building blocks. Herein, we report the highly enantioselective oxyalkynylation of diazo compounds using ethynylbenziodoxol-(on)e reagents and a simple copper bisoxazoline catalyst. The obtained α-benzoyloxy propargylic esters are useful building blocks
    允许将亲核试剂和亲电试剂添加到重氮化合物上的对映选择性催化方法可以快速进入重要的构建模块。在此,我们报告了使用乙炔基苯并氧醇-(on)e 试剂和简单的铜双恶唑啉催化剂对重氮化合物进行高度对映选择性的氧炔基化反应。获得的α-苯甲酰氧基炔丙酯是有用的结构单元,使用其他方法难以以对映体纯形式合成。所得产物可以有效地转化为邻二醇和α-羟基炔丙酯而不会损失对映体纯度。
  • One-Pot C–H Arylation/Lactamization Cascade Reaction of Free Benzylamines
    作者:Pratibha Chand-Thakuri、Vinod G. Landge、Mohit Kapoor、Michael C. Young
    DOI:10.1021/acs.joc.0c00542
    日期:2020.5.15
    ortho-arylation of benzylamines followed by in situ lactamization. This cascade sequence is enabled by the use of 2-iodobenzoates, which facilitates C-H arylation from the free amine under conditions that typically require an improved directing group approach. This reaction is characterized by a broad substrate scope with good functional group tolerance. The need for an ester versus carboxylic acid-functionalized
    已经开发出一种有效的方法,用于合成七元联芳基内酰胺,涉及钯催化的,天然胺导向的苄胺的正芳基化,然后进行原位内酰胺化。通过使用2-碘代苯甲酸酯使该级联序列成为可能,其在通常需要改进的导向基团方法的条件下促进游离胺的CH芳基化。该反应的特征在于底物范围广,具有良好的官能团耐受性。还探索了对酯对羧酸官能化的偶合剂的需求,以及合成八元联芳基内酰胺的潜力。还研究了各种应用,包括使用氮杂-油菜素内酯核心。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
cnmr
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐